Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study

TL Frandsen; J Abrahamsson; B Lausen; K Vettenranta

doi:10.1111/j.1365-2141.2011.08835.x

Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study

TL Frandsen, J Abrahamsson, B Lausen, K Vettenranta

Department of Paediatrics

Research output: Contribution to journal › Article › Scientific › peer-review

9 Citations (Scopus)

Original language	English
Pages (from-to)	244-247
Journal	British Journal of Haematology
Volume	155
Issue number	2
DOIs	https://doi.org/10.1111/j.1365-2141.2011.08835.x
Publication status	Published - 2011
Publication type	A1 Journal article-refereed

Access to Document

10.1111/j.1365-2141.2011.08835.x

Cite this

Frandsen, TL., Abrahamsson, J., Lausen, B., & Vettenranta, K. (2011). Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study. British Journal of Haematology, 155(2), 244-247. https://doi.org/10.1111/j.1365-2141.2011.08835.x

Frandsen, TL ; Abrahamsson, J ; Lausen, B ; Vettenranta, K. / Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study. In: British Journal of Haematology. 2011 ; Vol. 155, No. 2. pp. 244-247.

@article{69d6ba6e468949c2b48b9fcbbb311e47,

title = "Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study",

author = "TL Frandsen and J Abrahamsson and B Lausen and K Vettenranta",

year = "2011",

doi = "10.1111/j.1365-2141.2011.08835.x",

language = "English",

volume = "155",

pages = "244--247",

journal = "British Journal of Haematology",

issn = "0007-1048",

publisher = "Wiley",

number = "2",

}

Frandsen, TL, Abrahamsson, J, Lausen, B & Vettenranta, K 2011, 'Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study', British Journal of Haematology, vol. 155, no. 2, pp. 244-247. https://doi.org/10.1111/j.1365-2141.2011.08835.x

Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study. / Frandsen, TL; Abrahamsson, J; Lausen, B; Vettenranta, K.

In: British Journal of Haematology, Vol. 155, No. 2, 2011, p. 244-247.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study

AU - Frandsen, TL

AU - Abrahamsson, J

AU - Lausen, B

AU - Vettenranta, K

PY - 2011

Y1 - 2011

U2 - 10.1111/j.1365-2141.2011.08835.x

DO - 10.1111/j.1365-2141.2011.08835.x

M3 - Article

VL - 155

SP - 244

EP - 247

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 2

ER -

Frandsen TL, Abrahamsson J, Lausen B, Vettenranta K. Individualized toxicity-titrated 6-mercaptopurine increments during high-dose methotrexate consolidation treatment of lower risk childhood acute lymphoblastic leukaemia. A Nordic Society of Paediatric Haematology and Oncology (NOPHO) pilot study. British Journal of Haematology. 2011;155(2):244-247. https://doi.org/10.1111/j.1365-2141.2011.08835.x